PP01.142: First Results from the COCOON Treatment Substudy in Managing Moderate to Severe Dermatologic Adverse Events in Participants with EGFR-mutated Advanced NSCLC Treated with First-line Amivantamab-Lazertinib
Author:
Alexander I. Spira,Maxwell B. Sauder,Jill Feldman,Janellen Smith,Nicolas Girard,Weimin Li,Farastuk Bozorgmehr,Milena Mak,Tonatiuh Romero,Yichuan Xia,Shubin Sheng,Mehregan Nematian-Samani,Jairo Simoes,Mark Wildgust,Byoung Chul Cho
Publication:
Journal of Thoracic Oncology
Copyright © 2026 Published by Elsevier Inc.